Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 806 | 1,583 | 1,957 | 2,055 | 1,960 |
| Gross Profit | 806 | 1,583 | 1,957 | 2,055 | 1,960 |
| Operating Expenses | 18,441 | 20,288 | 19,850 | 14,658 | 15,413 |
| Operating Income | -17,635 | -18,705 | -17,893 | -12,603 | -13,453 |
| Interest Expense | 52 | 62 | 71 | 70 | 65 |
| Other Income | 1,307 | 1,729 | 1,919 | 1,920 | 964 |
| Pre-tax Income | -16,380 | -17,038 | -16,045 | -10,753 | -12,554 |
| Net Income Continuous | -16,380 | -17,038 | -16,045 | -10,753 | -12,554 |
| Net Income | $-16,380 | $-17,038 | $-16,045 | $-10,753 | $-12,554 |
| EPS Basic Total Ops | -0.44 | -0.46 | -0.43 | -0.29 | -0.42 |
| EPS Basic Continuous Ops | -0.44 | -0.46 | -0.43 | -0.29 | -0.42 |
| EPS Diluted Total Ops | -0.44 | -0.46 | -0.43 | -0.29 | -0.42 |
| EPS Diluted Continuous Ops | -0.44 | -0.46 | -0.43 | -0.29 | -0.42 |
| EBITDA(a) | $-17,472 | $-17,961 | $-17,894 | $-12,983 | $-13,048 |